About PreCision Dermatology
PreCision Dermatology is a Healthcare company based in Cumberland (United States) founded in 2010, and was acquired by Bausch Health in February 2014. Dermatology products are developed, manufactured, and marketed by PreCision Dermatology. PreCision Dermatology has raised $74 million across 3 funding rounds from investors including Golub Capital, Bausch Health and Frazier Healthcare Partners. Its focus areas include Traditional Pharmaceuticals, Generics and Therapeutic Areas.
Company details
PreCision Dermatology was founded in 2010 and operates as a subsidiary of Valeant Pharmaceuticals in Cumberland, United States. Dermatology products are developed, manufactured, and marketed by the company, focusing on pharmaceutical treatments for conditions such as acne, seborrheic dermatitis, atopic dermatitis, dermatoses, and rosacea. Items like Locoid and Clindagel are offered to support skin barrier restoration and related therapies within the pharmaceutical sector.
- Headquarters Cumberland, United States
- Stage Acquired
- SectorsHealthcare
- Website precisionderm.com
- Social LinkedIn
- Acquired by Bausch Health (Feb 2014)
- Total Equity Funding$74M (USD)
in 3 rounds
- Latest Funding Round$67M (USD), Debt – Venture
Sep 2013
- InvestorsGolub Capital
& 7 more
- Acquired byBausch Health
(Feb 2014)
Funding Insights of PreCision Dermatology
PreCision Dermatology has successfully raised a total of $74M across 3 strategic funding rounds. The most recent funding activity was a Debt β Venture round of $67 million completed in September 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $74M
- Total Rounds 3
- Last Round Debt – Venture β $67M
- First Round $19M
(Nov 2010)
- Investors Count 7
All 3 funding rounds of PreCision Dermatology with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2013 | $67M | Debt – Venture | β | β | |
| Nov 2012 | $55M | Series B | β | β | β |
| Nov 2010 | $19M | Series A | β | β | β |
8 investors in total: 8 institutional.
Investors in PreCision Dermatology
PreCision Dermatology has secured backing from 8 investors, including institutional and venture fund investors. Prominent investors backing the company include Golub Capital, Bausch Health and Frazier Healthcare Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Healthcare sector private equity investments are managed by the firm. | 1991 | frazierhealthcare.com | Seattle, United States | |
Private equity firm focused on life science sector | longitudecapital.com | Menlo Park, United States | ||
PE firm focused on life science and healthcare companies | novaquest.com | Raleigh, United States | ||
US-focused private equity and venture capital investments are managed. | bostonmillenniapartners.com | Boston, United States | ||
Growth-stage healthcare companies are invested in by EW Healthcare Partners. | ewhealthcare.com | New York, United States | ||
| quakerpartners.com | ||||
Private debt investments are managed for U.S. middle market companies. | 1994 | golubcapital.com | Chicago, United States | |
Therapeutics for multiple diseases including dermatology and neurology are developed. | 1960 | bauschhealth.com | Laval, Canada |
Investor details for PreCision Dermatology
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of PreCision Dermatology
4 dated milestones of PreCision Dermatology across 4 years, from founding to its latest funding, stage changes and deals.
- Founded PreCision Dermatology is founded.
- Funding First funding round of $19.0M.
- Funding Latest funding round, Debt β Venture, of $67.0M.
- Exit Acquired by Bausch Health.
Top companies in Traditional Health & Nutrition
3 companies that operate in the same segment as PreCision Dermatology (Traditional Health & Nutrition) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Manufacturer of generics formulations | 2002 | Bridgewater, New Jersey, United States | USD 3.02 B | 8,300 | ||
Biosimilar therapeutics are developed for oncology and autoimmune diseases. | 2010 | Redwood City, California, United States | USD 143.62 M | USD 42.17 M | 228 | |
Ophthalmic pharmaceuticals and instruments are developed for eye care. | 1853 | Bridgewater, New Jersey, United States | USD 5.1 B | 13,500 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about PreCision Dermatology
PreCision Dermatology was founded in 2010.
PreCision Dermatology is headquartered in Cumberland, United States.
PreCision Dermatology is a funded company, having raised a total of $74M across 3 funding rounds to date. The company's 1st funding round was a Series A of $19M, raised on Nov 2010.
PreCision Dermatology was founded in 2010 and operates as a subsidiary of Valeant Pharmaceuticals in Cumberland, United States. Dermatology products are developed, manufactured, and marketed by the company, focusing on pharmaceutical treatments for conditions such as acne, seborrheic dermatitis, atopic dermatitis, dermatoses, and rosacea. Items like Locoid and Clindagel are offered to support skin barrier restoration and related therapies within the pharmaceutical sector.
PreCision Dermatology has 8 investors. Key investors include Golub Capital, Bausch Health, Frazier Healthcare Partners, Longitude Capital, and NovaQuest Capital Management.
Yes. PreCision Dermatology was acquired by Bausch Health in February 2014.
